anmelden
FTSE All-Share
5.850,42
PKT
+17,79
PKT
+0,31
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.11.21 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 08.11.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 08.11.21 | GSK Neutral | UBS AG | |
| 05.11.21 | London Stock Exchange (LSE) Buy | Goldman Sachs Group Inc. | |
| 05.11.21 | GSK Equal Weight | Barclays Capital | |
| 05.11.21 | BP Hold | Jefferies & Company Inc. | |
| 03.11.21 | BP Buy | UBS AG | |
| 03.11.21 | BP Hold | Deutsche Bank AG | |
| 03.11.21 | BP Overweight | JP Morgan Chase & Co. | |
| 03.11.21 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.11.21 | AstraZeneca Buy | UBS AG | |
| 02.11.21 | BP Overweight | JP Morgan Chase & Co. | |
| 02.11.21 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.11.21 | BP Sector Perform | RBC Capital Markets | |
| 02.11.21 | Rio Tinto Outperform | Credit Suisse Group | |
| 02.11.21 | BP Hold | Jefferies & Company Inc. | |
| 02.11.21 | Diageo Outperform | Credit Suisse Group | |
| 02.11.21 | HSBC Buy | Goldman Sachs Group Inc. | |
| 02.11.21 | Barclays Buy | Goldman Sachs Group Inc. | |
| 01.11.21 | HSBC Buy | UBS AG | |
| 01.11.21 | Unilever Market-Perform | Bernstein Research | |
| 01.11.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 01.11.21 | BP Sector Perform | RBC Capital Markets | |
| 29.10.21 | Shell (ex Royal Dutch Shell) Buy | Deutsche Bank AG | |
| 29.10.21 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 28.10.21 | GSK Hold | Deutsche Bank AG | |
| 28.10.21 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 28.10.21 | GSK Neutral | UBS AG | |
| 28.10.21 | GSK Hold | Kepler Cheuvreux | |
| 28.10.21 | GSK Underperform | Credit Suisse Group | |
| 28.10.21 | GSK Underweight | Barclays Capital | |
| 28.10.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 28.10.21 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 28.10.21 | Vodafone Group Overweight | JP Morgan Chase & Co. | |
| 27.10.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 27.10.21 | GSK Buy | Goldman Sachs Group Inc. | |
| 27.10.21 | GSK Buy | Jefferies & Company Inc. | |
| 27.10.21 | HSBC Outperform | RBC Capital Markets | |
| 26.10.21 | HSBC Sell | Deutsche Bank AG | |
| 26.10.21 | AstraZeneca Buy | Deutsche Bank AG |
